Sign In

Gaetano Scuderi, MD

Orthopaedic Surgeon 4th Degree VB jiujitsu black belt

Dr. Gaetano Scuderi, MD, is a prominent figure in the field of musculoskeletal diseases, with a focus on diagnostic and therapeutic solutions for conditions like osteoarthritis and back and joint pain.

His mission is to lead the way in developing advanced diagnostic products for musculoskeletal diseases and innovative biologic therapies for conditions such as osteoarthritis.

Cytonics Corporation, a company Dr. Scuderi has been deeply involved with, offers groundbreaking diagnostic solutions like the patented FACT™ assay, which helps identify the source of a patient's pain by detecting the Fibronectin-Aggrecan Complex (FAC) in fluid samples.

On the therapeutic front, Cytonics is pioneering autologous treatments for osteoarthritis and other related conditions. Their APIC™ System, endorsed by FDA through a 510(k) clearance, shows promise in slowing down osteoarthritis progression.

Dr. Scuderi's education includes a medical degree from the University at Buffalo, with previous academic tenures at Stony Brook University and Iona High School.

His professional journey features roles such as Orthopaedic Surgeon at Palm Beach Spine and Sport, Chief Medical Officer and Founder at Cytonics Corporation, Clinical Assistant Professor of Orthopaedic Surgery at Stanford University, and positions in spine and orthopaedic surgery at reputable institutions like UC San Diego and the University of Miami.

Highlights

Aug 26 · linkedin

Sincere thanks to everyone who participated in this round!

Cytonics Corporation has raised over $4.6M this year from retail investors via equity crowdfunding. This has allowed us to advance our lead drug candidate for osteoarthritis into Phase 1 clinical trials.

With 19 out of 22 patients dosed, we are one step closer to developing the first and only disease-modifying therapy for OA.

#biotechnology #crowdfunding #arthritis #regenerativemedicine #investing #venturecapital #drugdevelopment #clinicaltrials

Aug 25 · linkedin

💵 $916K raised, converging on 🎯 $1M target!

Ready to become a shareholder in a private biotech (pre-IPO*)?

Visit invest.cytonics.com.

Opportunity ends TONIGHT!

*While Cytonics Corporation has outlined a potential exit strategy that may include an Initial Public Offering (IPO), this outcome is not guaranteed. The occurrence of an IPO depends on a variety of factors that are beyond the company's control, and there is no assurance that such an event will occur.

#biotechnology #crowdfunding #IPO #venturecapital #arthritis #regenerativemedicine #investing

Gaetano Scuderi, MD
Add to my network

Location

Jupiter, Florida, United States